Washington Trust Bank’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-250
Closed -$5K 846
2016
Q1
$5K Buy
250
+100
+67% +$1.9K ﹤0.01% 647
2015
Q4
$5K Hold
150
﹤0.01% 657
2015
Q3
$3K Hold
150
﹤0.01% 716
2015
Q2
$6K Buy
150
+50
+50% +$1.64K ﹤0.01% 708
2015
Q1
$3K Hold
100
﹤0.01% 754
2014
Q4
$4K Buy
+100
New +$2.49K ﹤0.01% 795

Other funds holding MGNX

Washington Trust Bank's MGNX Position: Q2 2016 in Review

Washington Trust Bank sold out of MacroGenics (MGNX) in Q2 2016, closing a stake of 250 shares — an estimated $5K sold.

Washington Trust Bank first reported a position in MGNX in Q4 2014 and held it in 6 quarters. The position peaked at $6K in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q2 2016.

  • Washington Trust Bank reported no remaining MacroGenics position as of Q2 2016 after selling out during the quarter.
  • Washington Trust Bank sold 250 MacroGenics shares in Q2 2016, an estimated $5K.
  • Washington Trust Bank first reported a position in MacroGenics in Q4 2014 and held it in 6 quarters.
  • Washington Trust Bank's MacroGenics position peaked at $6K in Q2 2015.
  • 125 funds tracked by Wall St. Rank held MacroGenics as of Q2 2016.

Based on Washington Trust Bank's 13F filing for Q2 2016, filed 7 Jul 2016.